Current Valuation
N/A
As of August 6, 2025
Total Funding Raised
$11.3M
Last Round
Early Stage VC

$1.8M

Last Funding
Aug 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Synthesis Health is currently valued at N/A as of August 6, 2025. The company has raised a total of $11.3M in funding.

Investment Perspective

Synthesis Health's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Synthesis Health Valuation Updates

Get notified when Synthesis Health raises new funding or valuation changes

What is Synthesis Health Worth in 2025?

As of 2025, Synthesis Health is valued at N/A, based on the company's Early Stage VC funding round in August 6, 2025. This valuation positions Synthesis Health as one of the leading private companies in the sector.

Synthesis Health Valuation History

Synthesis Health's funding history demonstrates steady growth and investor confidence.

How Synthesis Health Valuation is Determined

Private company valuations like Synthesis Health's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Synthesis Health Valuation FAQs

Is Synthesis Health profitable?

Synthesis Health has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Synthesis Health's valuation compare to competitors?

Synthesis Health is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Synthesis Health IPO?

Synthesis Health has not announced plans for an initial public offering. Until an IPO, investors can access Synthesis Health shares through secondary market platforms.